恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01276 恒瑞医药

交易中 12-05 13:27:40

73.250

+0.350

+0.48%

最高73.400	最低72.300	成交量82.54万
今开72.900	昨收72.900	日振幅1.51%
总市值4,862亿	流通市值188.99亿	总股本66.37亿
成交额6,038万	换手率0.32%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":73.25,"timestamp":1764912391371,"preClose":72.9,"halted":0,"volume":825355,"delay":0,"floatShares":258000000,"shares":6637000000,"eps":1.1011715253181802,"marketStatus":"交易中","change":0.35,"latestTime":"12-05 13:27:40","open":72.9,"high":73.4,"low":72.3,"amount":60375906,"amplitude":0.015089,"askPrice":73.25,"askSize":6000,"bidPrice":73.15,"bidSize":3800,"shortable":3,"etf":0,"ttmEps":1.277588013046355,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764922200000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":72.9,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.835787,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":61.2,"timestamp":1764912456000,"preClose":61.25,"halted":0,"volume":11957000,"delay":0,"premium":"+8.69"}},"requestUrl":"/m/hq/s/01276","defaultTab":"news","newsList":[{"id":"2589359268","title":"每日卖空追踪 | 恒瑞医药 12月04日卖空量成交4.78万股，卖空比例为1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589359268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589359268?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837021,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间12月04日，涨1.53%，卖空量成交4.78万股，较上一交易日减少87.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163234a4cc36ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163234a4cc36ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","BK1191","LU2543165471.USD","01276","LU0359201612.USD","LU1023057109.AUD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2589835907","title":"恒瑞医药12月04日获主力加仓808.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589835907","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589835907?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836124,"startTime":"0","endTime":"0","summary":"12月04日, 恒瑞医药股价涨1.53%，报收72.90元，成交金额1.9亿元，换手率1.01%，振幅1.95%，量比1.25。恒瑞医药今日主力资金净流入808.5万元，连续5日净流入，上一交易日主力净流入1367.8万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为75.00%，平均涨幅为1.49%。该股近5个交易日下跌2.41%，主力资金累计净流入4075.4万元；近20日主力资金累计净流入1.6亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161630a4cc2cbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161630a4cc2cbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","01276","LU0359201612.USD","BK1191","LU2543165471.USD","LU0359201885.HKD","LU1023057109.AUD"],"gpt_icon":1},{"id":"2589983590","title":"礼来前高管加入恒瑞医药；强生医疗科技进行大规模组织重组；三星生物宣布进一步扩大CDMO能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983590","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589983590?lang=zh_cn&edition=full","pubTime":"2025-12-04 13:26","pubTimestamp":1764825999,"startTime":"0","endTime":"0","summary":"强生医疗科技正进行大规模组织重组，旨在改变业务单元运作方式，以适应市场变化，提升竞争力。强生医疗科技领导层表示，自2026年1月1日起，公司将在全球范围内从区域模式转向业务单元主导的运营模式。本次合作将进一步强化先声药业在抗感染领域的产品布局。健友股份公告，近日收到美国食品药品监督管理局签发的丙泊酚乳状注射液的ANDA批准通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204132642a722fe91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204132642a722fe91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU0359202008.SGD","LU1023057109.AUD","LU2543165471.USD","LU0359201885.HKD","BK1191","LU0359201612.USD"],"gpt_icon":0},{"id":"2588109870","title":"富时中国50指数调整：纳入中国宏桥(01378)、宁德时代(03750)、恒瑞医药(01276)，剔除中信建投证券(06066)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2588109870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588109870?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:40","pubTimestamp":1764758405,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月3日，富时罗素宣布对富时中国50指数、富时中国A50指数、富时中国A150指数、富时中国A200指数及富时中国A400指数进行审议调整，该调整将于2025年12月19日(星期五)收盘后生效。其中，本次富时中国50指数成分股将纳入中国宏桥、宁德时代、恒瑞医药等港股，将剔除中信建投证券H股、长城汽车H股、理想汽车-W等港股公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01378","LU0140636845.USD","LU1224709979.USD","LU1781817850.SGD","LU0011963245.USD","LU1166156734.SGD","BK0239","03750","LU0516422440.USD","LU1861214812.USD","LU0359201612.USD","LU0328353924.USD","LU0531971595.HKD","EVS.SI","LU0594300179.USD","LU0463099449.HKD","LU2506952410.USD","LU1152091168.USD","LU2506951792.HKD","LU0651946864.USD","JKS","LU2580892789.USD","LU0039217434.USD","LU0231483743.USD","LU0072462343.USD","LU0651947912.USD","LU1979443071.USD","LU0302445910.USD","LU1934453819.USD","IE00B8L5B284.USD","LU0880133367.SGD","LU2348774022.SGD","LU2495084118.USD","LU1719994722.HKD","300750","LU0106252389.USD","01276","600276","LU0107464264.USD","LU1064131003.USD","LU0326950275.SGD","LU0611395673.USD","LU0702159699.USD","LU1861219969.SGD","LU1794554557.SGD","BK1500","BK4526","06066","LU0821914370.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2588014759","title":"恒瑞医药最新公告：董事会提名聘任朱国新为公司高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014759","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014759?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:34","pubTimestamp":1764754490,"startTime":"0","endTime":"0","summary":"恒瑞医药公告称，公司第九届董事会第二十次会议于2025年12月3日召开，会议审议并通过了《关于提名聘任公司高级副总裁的议案》，提名聘任朱国新为公司高级副总裁，任期自本次董事会审议通过之日起至本届董事会任期届满为止。朱国新拥有30余年全球跨职能药物发现领导经验，涉及多个疾病领域。加入恒瑞医药前，他在礼来新药研发中心担任副总裁，领导了多个发现研究和早期开发项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300027544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","LU1328615791.USD","LU0405327148.USD","LU2495084118.USD","LU2488822045.USD","LU1146622755.USD","LU1969619763.USD","LU1997245094.SGD","LU2580892789.USD","LU2097828714.EUR","LU1997244956.HKD","LU0359202008.SGD","LU2543165471.USD","BK0239","LU1781817850.SGD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","BK0196","LU2580892862.HKD","BK1191","LU1997245177.USD","LU1820825898.SGD","LU0359201612.USD","BK0183","01276","LU2097828805.USD","LU0405327494.USD","LU1655091616.SGD","LU2097828474.EUR","LU2328871848.SGD","BK0060","LU1255011170.USD","BK0012","LU1023057109.AUD","LU2097828557.USD","LU2097828631.EUR","LU2289578879.USD","600276","LU0359201885.HKD","LU1580142542.USD"],"gpt_icon":0},{"id":"2588101655","title":"智通AH统计|12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588101655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588101655?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月3日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为900.00%、276.85%、265.79%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-4.88%、-0.25%、1.71%。其中广和通、东北电气、晨鸣纸业的偏离值位居前三，分别为49.00%、36.60%、26.74%；另外，广汽集团、均胜电子、江苏宁沪高速公路的偏离值位居后三，分别为-26.76%、-18.54%、-15.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03606","IE00BVYPNQ40.USD","LU0314109678.HKD","00300","00187","LU0828237510.HKD","00995","LU0214875030.USD","02899","00916","06066","159982","399300","IE00BZ18W340.USD","LU0791590937.USD","02238","00553","01988","03143","BK1583","00638","01276","02338","02359","03678","01033","02866","01349","03968","LU2125910500.SGD","00177","01812","00670","06031","00317","00548","00699","00719","LU1880383366.USD","01330","BK1582","03750","01057","00753","01635","01108","LU0370786039.SGD","00042","02218"],"gpt_icon":1},{"id":"2588398720","title":"恒瑞医药回购890万股 金额5.95亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588398720","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588398720?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:37","pubTimestamp":1764668274,"startTime":"0","endTime":"0","summary":"12月2日，恒瑞医药（600276/01276）发布公告，截至2025年11月30日已回购890万股，占总股本的0.13%，回购资金总额为5.95亿元，回购价格区间为59.32元/股至70元/股。2025年前三季度，恒瑞医药实现收入231.88亿元，归母净利润57.51亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512023580451214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997244956.HKD","BK0183","LU0405327494.USD","BK0060","LU2289578879.USD","LU2097828714.EUR","BK0012","LU1023057109.AUD","01276","LU1997245094.SGD","LU1997245177.USD","LU2543165471.USD","LU2097828474.EUR","LU2488822045.USD","LU2148510915.USD","LU1064130708.USD","LU2495084118.USD","LU2097828805.USD","LU2328871848.SGD","LU1580142542.USD","600276","BK0239","LU1064131003.USD","LU2580892789.USD","LU1146622755.USD","LU2580892862.HKD","BK0196","LU1655091616.SGD","LU0359202008.SGD","BK0028","LU1328615791.USD","LU1781817850.SGD","LU2097828631.EUR","LU1255011170.USD","BK0188","LU1820825898.SGD","BK1191","LU2097828557.USD","LU1969619763.USD","LU0359201612.USD","LU0405327148.USD","LU0359201885.HKD"],"gpt_icon":0},{"id":"2588033714","title":"每日卖空追踪 | 恒瑞医药 12月02日卖空量成交18.4万股，卖空比例为12.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033714?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664218,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间12月02日，跌1.44%，卖空量成交18.4万股，较上一交易日减少11.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163227a4c79e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163227a4c79e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU2543165471.USD","BK1191","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2588033723","title":"中国药品价格登记系统正式上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033723","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033723?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:45","pubTimestamp":1764661540,"startTime":"0","endTime":"0","summary":"在活动现场，国家医保局正式发布《关于开展药品价格登记查询服务的公告》，并与北京市人民政府共同启动中国药品价格登记系统，委托西城区国资企业采取社会化运营模式，按照“一地受理、全国共享、全球公开”的经办原则，同步在线上线下为国内外医药企业提供药品价格登记查询服务。借鉴国际做法，国家医保局发起建设中国药品价格登记系统，对推动医药高质量发展具有深远影响和重要意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202154642a71ea1f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202154642a71ea1f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1574","LU0359201885.HKD","01276","LU2543165471.USD","BK1161","LU1023057109.AUD","LU0359201612.USD","BK1191","LU0359202008.SGD"],"gpt_icon":0},{"id":"2588033793","title":"凌科药业递交赴港IPO申请：核心在研产品面临同类竞品挤压，短期现金流恶化","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033793","media":"蓝鲸新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033793?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:37","pubTimestamp":1764661069,"startTime":"0","endTime":"0","summary":"《招股书》显示，凌科药业定位为自身免疫及炎症疾病领域创新药企，核心管线聚焦JAK-STAT信号通路，拥有三款临床阶段候选药物。若IPO募资不及预期，核心产品III期临床可能因资金不足被迫中断。总体而言，凌科药业在JAK抑制剂领域布局具有一定潜力，但其财务数据不容乐观，赴港IPO或许是此类公司生死时速中的必然选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120215441895263f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120215441895263f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","01276","LU1023057109.AUD","LLY","BK1191","LU2543165471.USD","LU0359201612.USD","LU0359201885.HKD"],"gpt_icon":0},{"id":"2588033058","title":"恒瑞重磅新药又一适应症申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033058","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033058?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:17","pubTimestamp":1764649023,"startTime":"0","endTime":"0","summary":"12 月 2 日，CDE 官网显示，恒瑞医药的注射用甲苯磺酸瑞马唑仑递交了一项新适应症上市申请。根据该药的临床研究进度，Insight 数据库推测本次申报的适应症可能为用于重症监护期间镇静。此前，恒瑞瑞马唑仑已在国内获批 4 项适应症，包括用于常规胃镜检查镇静、结肠镜检查的镇静、全身麻醉诱导和维持以及支气管镜诊疗麻醉。目前，恒瑞还在拓展瑞马唑仑的新适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202141957a4c75867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202141957a4c75867&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU0359201612.USD","LU2543165471.USD","LU0359201885.HKD","LU1023057109.AUD","01276","LU0359202008.SGD"],"gpt_icon":0},{"id":"2588727841","title":"GIC Private Limited增持恒瑞医药(01276)42.24万股 每股作价约74.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727841","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588727841?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:27","pubTimestamp":1764592054,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月27日，GIC Private Limited增持恒瑞医药(01276)42.24万股，每股作价74.955港元，总金额约为3166.1万港元。增持后最新持股数目为5946.22万股，最新持股比例为23.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0405327148.USD","LU1997245177.USD","LU2328871848.SGD","LU1580142542.USD","LU2488822045.USD","LU1064131003.USD","BK0183","LU1328615791.USD","LU2495084118.USD","LU1781817850.SGD","LU0359201612.USD","LU2097828557.USD","LU0405327494.USD","BK0028","LU1655091616.SGD","BK0188","BK0060","LU0359202008.SGD","BK4104","LU2097828805.USD","LU2543165471.USD","LU1255011170.USD","LU2097828714.EUR","LU2148510915.USD","BK0196","LU0359201885.HKD","LU2289578879.USD","LU2097828631.EUR","GIC","LU1969619763.USD","LU1997244956.HKD","LU1997245094.SGD","LU2580892862.HKD","BK0239","LU1064130708.USD","600276","LU1023057109.AUD","BK0012","LU1820825898.SGD","LU2097828474.EUR","01276","LU2580892789.USD","LU1146622755.USD","BK1191"],"gpt_icon":0},{"id":"2588476777","title":"智通AH统计|12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588476777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588476777?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月1日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为881.82%、274.55%、269.74%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-5.03%、-1.36%、1.50%。其中广和通、大众公用、京城机电股份的偏离值位居前三，分别为31.56%、23.38%、20.11%；另外，江苏宁沪高速公路、均胜电子、中国人寿的偏离值位居后三，分别为-13.73%、-12.81%、-11.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03143","LU0918141887.USD","03750","00317","00914","IE0008368742.USD","01812","LU0164865239.USD","LU0918141705.HKD","02648","00548","00719","00177","159982","LU0456854461.SGD","03678","03606","02218","02338","02359","BK1185","01635","00670","00187","01276","399300","00699","01349","00553","02628","01057","02899","IE00BZ18W456.USD","LU1769817096.USD","06066","BK1567","BK1184","01072","00300","00995","00638","BK1123","00753","01108","01033","01055","00042","01988","03968"],"gpt_icon":1},{"id":"2587736728","title":"医药股新高的理由","url":"https://stock-news.laohu8.com/highlight/detail?id=2587736728","media":"真是港股圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587736728?lang=zh_cn&edition=full","pubTime":"2025-11-28 18:34","pubTimestamp":1764326058,"startTime":"0","endTime":"0","summary":"近期，部分医药股发生异动，行业龙头百济神州回归历史新高。但当前市场环境，依靠情绪或者概率不大的估值上调缺乏确定性，医药股的新高，还需要更多的理由来支撑。这一年来，医药行业平均的BD 10%首付款比例降低到5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128191044a4c04d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128191044a4c04d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","09995","BK1583","LU1969619763.USD","BK1515","01276","01801","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2586785109","title":"智通港股空仓持单统计|11月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586785109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586785109?lang=zh_cn&edition=full","pubTime":"2025-11-28 18:30","pubTimestamp":1764325805,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月21日，未平仓空单比位列前三位为万科企业、中远海控、恒瑞医药，空仓比分别为19.60%、16.49%、16.36%。未平仓空单比（绝对值）较上一次增加最多为中环新能源、万科企业、东方电气，分别增加2.58%、1.92%、1.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0561508036.HKD","06821","LU0650527681.SGD","PAImain","LU1770034418.SGD","02382","01276","HPAD.SI","IE00BZ08YT58.USD","03759","00763","000002","BK1507","PNGAY","01072","601318","82318","03888","02899","LNVGY","LU0918141887.USD","01428","01735","80992","LU1807302812.USD","06613","02228","01919","02318","02498","06680","LU0880133367.SGD","LU1794554557.SGD","09696","00992","01951","LU0630378692.HKD","LU1303224171.USD","01910","03145","LU0348805143.USD","LU0287142896.SGD","02202","LU0588545490.SGD","03800","01635","02359"],"gpt_icon":1},{"id":"2587473188","title":"分析 | 2025年中国创新药出海观察：机遇、模式与长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2587473188","media":"上海市企业走出...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587473188?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:48","pubTimestamp":1764319731,"startTime":"0","endTime":"0","summary":"2025年，中国创新药全球化进程高光频现。据央视财经报道，2025年国产创新药对外授权总金额已突破千亿美元，相较于2024年实现了翻倍式增长，我国在研新药数量占全球数量的比例超过20%，跃居全球新药研发第二位。在具体路径上，中国创新药出海目前可以理解为合作出海与自主出海两种模式。2025年，中国创新药的多笔重磅交易都采用了对外授权模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128190111a4c04825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128190111a4c04825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","LU0359202008.SGD","01276","BK1161","BK1191","LU1023057109.AUD","LU0359201885.HKD","LU2543165471.USD","LU0359201612.USD","BK1574"],"gpt_icon":0},{"id":"2586320425","title":"智通AH统计|11月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586320425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586320425?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:15","pubTimestamp":1764317706,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月28日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为864.29%、270.78%、268.92%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-5.29%、-1.61%、0.75%。其中广和通、大众公用、山东新华制药股份的偏离值位居前三，分别为23.08%、22.85%、20.46%；另外，广汽集团、中国南方航空股份、江苏宁沪高速公路的偏离值位居后三，分别为-15.57%、-12.01%、-10.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0329678337.USD","00177","01812","01880","02866","03678","01988","03968","399300","00187","00638","LU1048596156.SGD","LU0359201612.USD","01033","03750","00753","01276","02359","IE00BZ08YT58.USD","00042","01055","06066","LU0463099449.HKD","01528","LU0502904849.HKD","01057","02603","00317","02579","02628","02238","BK1552","01349","159982","01108","01635","LU0738912210.USD","00300","IE00B3M56506.USD","02899","01072","03143","06818","00719","02338","06031","00895","00553","02218"],"gpt_icon":1},{"id":"2587881731","title":"中国创新药BD热潮背后的法律风险隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2587881731","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587881731?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:17","pubTimestamp":1764314223,"startTime":"0","endTime":"0","summary":"2025年，中国创新药BD出海交易额达1042亿美元，首付款达81亿美元，均超去年全年总和。这些数据反映出中国创新药加速崛起并获得全球主流市场认可。亨利医药造假风波虽尚无定论，但已引发对BD交易潜在诉讼潮的警惕。知情人士称，国内真正精通复杂BD协议的律师不超过10人，导致大量协议可能存在条款漏洞。随着国产创新药持续发展及大药企面临专利悬崖，BD逻辑仍将延续。中国创新药出海始终在解决问题中前行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112815235997844565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112815235997844565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06978","LU2543165471.USD","BK1574","LU1023057109.AUD","BK1161","LU0359201612.USD","LU0359202008.SGD","01276","01093","LU0359201885.HKD"],"gpt_icon":0},{"id":"2587873188","title":"《经济学人》撰文：中国创新药逆袭全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2587873188","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587873188?lang=zh_cn&edition=full","pubTime":"2025-11-28 12:18","pubTimestamp":1764303507,"startTime":"0","endTime":"0","summary":"2019年11月，百济神州成为首家获得美国FDA批准的中国癌症药物开发商。中国企业从药物发现到人体试验的时间约为全球平均水平的一半。\"国际药物巨头正在争相购买来自中国的创新药物分子。《经济学人》指出，中国医药的崛起时机微妙。对中国制药商而言，真正的考验不仅是发明有效的新疗法，还要打入新市场并通过相关监管障碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128122009a716a2a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128122009a716a2a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","01276","BK1574","BK1161","LU1023057109.AUD","LU2543165471.USD","LU0359201885.HKD","LU0359202008.SGD","09926","LU0359201612.USD","BK1191"],"gpt_icon":0},{"id":"2586127392","title":"恒瑞医药获大摩增持约177.06万股 每股均价69.65港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586127392","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586127392?lang=zh_cn&edition=full","pubTime":"2025-11-28 07:27","pubTimestamp":1764286020,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，11月24日，大摩增持恒瑞医药（01276）177.0645万股，每股均价69.65港元，总金额约为1.23亿港元。增持后最新持股数目约为2084.8万股，最新持股比例为8.07%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-28/doc-infywyzq8672404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1668664300.SGD","LU1244550494.USD","LU0359202008.SGD","LU1023057109.AUD","IE00BZ1G4Q59.USD","600276","LU1255011170.USD","LU1969619763.USD","LU1074936037.SGD","BK0183","LU2097828714.EUR","LU1820825898.SGD","LU1162221912.USD","BK0196","BK4534","LU1720051017.SGD","LU1720051108.HKD","LU2148510915.USD","LU2580892862.HKD","LU2328871848.SGD","BK4588","LU0006306889.USD","LU1655091616.SGD","LU0405327148.USD","LU2289578879.USD","LU0359201612.USD","BK0012","LU1244550221.USD","BK4516","BK0028","LU2543165471.USD","LU1997245094.SGD","LU0234570918.USD","LU0359201885.HKD","LU2133065610.SGD","LU2357305700.SGD","LU0225283273.USD","LU1328615791.USD","LU2028103732.USD","LU0158827781.USD","01276","LU1064130708.USD","LU2580892789.USD","BK0188","LU0314104364.USD","LU0528227936.USD","LU1791710582.SGD","LU2097828557.USD","BK1191","LU1732800096.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":-0.0234},{"period":"1month","weight":0.0203},{"period":"3month","weight":-0.1543},{"period":"6month","weight":0.2667},{"period":"1year","weight":0.6549},{"period":"ytd","weight":0.6549}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏恒瑞医药股份有限公司是一家主要从事药品的研发、生产和销售的中国公司。该公司专注于肿瘤领域，覆盖激酶抑制剂、抗体偶联药物（ADC）、肿瘤免疫、激素受体调控、脱氧核糖核酸（DNA）修复及表观遗传、支持治疗等研究领域。该公司的产品包括抗肿瘤、镇痛麻醉和造影剂，应用于自身免疫疾病、代谢性疾病、心血管疾病、感染疾病、呼吸系统疾病、血液疾病、疼痛管理、神经系统疾病、眼科、肾病等领域。该公司主要在国内外市场开展其业务。","exchange":"SEHK","name":"恒瑞医药","nameEN":"HENGRUI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,01276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}